Novavax Inc (NVAX) Stock Price, Quote & News

Company Profile

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the...

Industry: Biotechnology

Sector: Healthcare

Phone: 240 268 2000

Website: www.novavax.com

Address:

700 Quince Orchard Road, Gaithersburg, United States

andy4343 Apr. 25 at 2:48 PM

$NVAX Novavax has spent over 4 billion dollars on Research and Development in the last 10 years and is still only worth 1.2 billion. This too shall pass.

1 · Reply

Paulchowda Apr. 25 at 11:16 AM

$NVAX it’s just playing possum, I stretched my legs about 1130ish this fell in pool, dried off and fed grapes this morning. It’s always me.🤷‍♂️

3 · Reply

Trader00995 Apr. 25 at 8:54 AM

$NVAX

1 · Reply

Jordand91 Apr. 25 at 2:50 AM

$NVAX is JJ ever gonna fuck off? I have no idea why this guy is still the ceo

0 · Reply

Kikii2 Apr. 25 at 1:23 AM

$NVAX Interesting couple of weeks coming up. May 5 Pfizer earnings date. May announce which candidates are using Matrix M May 7 Novavax earnings (estimate) Hate to say it but probably a nothing burger. Then again maybe some news we all have been waiting for. Nah, that's too much optimism. Couple of weeks, phase 2 CIC results from Sanofi and announcement of phase 3. Of course if it didn't fail altogether.

1 · Reply

shibacuty Apr. 25 at 1:05 AM

$NVAX target price?

0 · Reply

ejaXstoXX Apr. 25 at 12:57 AM

$NVAX 46.3M shorted shares 14.9D to cover

1 · Reply

KidTrader999 Apr. 24 at 11:51 PM

$NVAX very odd trading with NVAX today, for a Friday. I’m feeling there is news next week. I’m pretty much all in… again. Let’s wait and see

0 · Reply

simplehumble Apr. 24 at 11:32 PM

$NVAX - May or June Heading to Moon !!! Have a nice weekend!!

0 · Reply

BigCheeze2014 Apr. 24 at 11:11 PM

$NVAX Shorts are in command. Shah is full of hot air…can’t do shit!

0 · Reply

Novavax Faces Shareholder Revolt As Shah Capital Criticizes Strategy

Apr 8, 2026, 6:08 AM EDT - 17 days ago

Shah Capital intends to vote against Novavax's board nominees, executive compensation

Mar 30, 2026, 8:00 AM EDT - 26 days ago

Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

Mar 10, 2026, 3:40 PM EDT - 6 weeks ago

Novavax Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 2:30 PM EST - 7 weeks ago

Novavax Transcript: TD Cowen 46th Annual Health Care Conference

Feb 27, 2026, 2:20 PM EST - 2 months ago

What's Going On With Novavax Stock On Friday?

Feb 26, 2026, 4:30 PM EST - 2 months ago

Novavax to Participate in Upcoming Investor Conferences

Feb 26, 2026, 2:19 PM EST - 2 months ago

COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb

Feb 26, 2026, 8:30 AM EST - 2 months ago

Novavax Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:06 AM EST - 2 months ago

Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals

Feb 26, 2026, 8:00 AM EST - 2 months ago

Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Feb 19, 2026, 8:00 AM EST - 2 months ago

Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Jan 20, 2026, 7:15 AM EST - 3 months ago

Novavax Announces Entering into a License Agreement with Pfizer

Jan 20, 2026, 7:11 AM EST - 3 months ago

Novavax enters license agreement with Pfizer for vaccine development

PFE

Jan 14, 2026, 7:30 PM EST - 3 months ago

Novavax Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 3 months ago

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 1, 2025, 3:50 PM EST - 5 months ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA PFE

Dec 1, 2025, 12:35 PM EST - 5 months ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX MRNA PFE

Dec 1, 2025, 9:59 AM EST - 5 months ago

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

MRNA

Nov 19, 2025, 11:30 AM EST - 5 months ago

Novavax Transcript: Jefferies London Healthcare Conference 2025

Nov 12, 2025, 4:41 PM EST - 5 months ago

Shah Capital pushes for Novavax sale, warns of proxy fight

Nov 12, 2025, 8:00 AM EST - 5 months ago

Novavax to Participate in Jefferies London Healthcare Conference

Nov 6, 2025, 8:30 AM EST - 6 months ago

Novavax Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 6 months ago

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Nov 6, 2025, 7:58 AM EST - 6 months ago

Novavax raises annual revenue forecast on strength of vaccine deals

Nov 4, 2025, 7:00 AM EST - 6 months ago

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Oct 30, 2025, 8:00 AM EDT - 6 months ago

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 22, 2025, 7:00 AM EDT - 6 months ago

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Oct 14, 2025, 1:08 PM EDT - 6 months ago

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

Oct 14, 2025, 6:09 AM EDT - 6 months ago

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Oct 7, 2025, 7:00 AM EDT - 7 months ago

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Sep 30, 2025, 9:01 AM EDT - 7 months ago

Novavax Announces Progress on Sanofi Agreement

Sep 19, 2025, 11:40 AM EDT - 7 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

BNTX MRNA PFE

Sep 4, 2025, 10:20 AM EDT - 8 months ago

Novavax Transcript: Cantor Global Healthcare Conference 2025

Sep 4, 2025, 8:00 AM EDT - 8 months ago

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Sep 3, 2025, 8:00 AM EDT - 8 months ago

Novavax to Participate in the Cantor Global Healthcare Conference

Aug 27, 2025, 3:07 PM EDT - 8 months ago

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Aug 21, 2025, 7:43 AM EDT - 8 months ago

Novavax Announces Convertible Debt Refinancing

Aug 6, 2025, 8:30 AM EDT - 9 months ago

Novavax Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:08 AM EDT - 9 months ago

Novavax beats quarterly revenue estimates on milestone payment

Aug 6, 2025, 8:00 AM EDT - 9 months ago

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Jul 30, 2025, 8:00 AM EDT - 9 months ago

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 24, 2025, 11:02 AM EDT - 9 months ago

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Jul 24, 2025, 8:00 AM EDT - 9 months ago

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Jun 11, 2025, 2:00 PM EDT - 11 months ago

Novavax Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 11, 2025, 7:11 AM EDT - 11 months ago

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Jun 11, 2025, 7:00 AM EDT - 11 months ago

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Jun 10, 2025, 10:45 AM EDT - 11 months ago

Vaccine actions and policy positions under US Health Secretary Kennedy

BNTX MRNA PFE

Jun 10, 2025, 9:30 AM EDT - 11 months ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

BNTX MRNA PFE

Jun 10, 2025, 8:18 AM EDT - 11 months ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

BNTX MRNA PFE SNY

May 20, 2025, 4:34 PM EDT - 1 year ago

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

May 19, 2025, 12:15 PM EDT - 1 year ago

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

AZO TSLA

May 19, 2025, 9:27 AM EDT - 1 year ago

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

May 19, 2025, 7:16 AM EDT - 1 year ago

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

May 19, 2025, 7:00 AM EDT - 1 year ago

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

May 17, 2025, 10:26 PM EDT - 1 year ago

FDA approves Novavax COVID vaccine with new conditions

May 14, 2025, 6:00 PM EDT - 1 year ago

Novavax Transcript: BofA Securities 2025 Healthcare Conference

May 8, 2025, 1:31 PM EDT - 1 year ago

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why

May 8, 2025, 11:12 AM EDT - 1 year ago

Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

May 8, 2025, 8:30 AM EDT - 1 year ago

Novavax Earnings Call Transcript: Q1 2025

May 8, 2025, 8:06 AM EDT - 1 year ago

Novavax swings to profit on lower expenses related to COVID shots

Mar 11, 2025, 3:40 PM EDT - 1 year ago

Novavax Transcript: Leerink’s Global Healthcare Conference 2025

Mar 4, 2025, 9:10 AM EST - 1 year ago

Novavax Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 27, 2025, 8:30 AM EST - 1 year ago

Novavax Earnings Call Transcript: Q4 2024

Nov 20, 2024, 6:00 AM EST - 1 year ago

Novavax Transcript: Jefferies London Healthcare Conference 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Novavax Earnings Call Transcript: Q3 2024

Sep 10, 2024, 3:10 PM EDT - 1 year ago

Novavax Transcript: Baird's 2024 Global Healthcare Conference

Sep 9, 2024, 3:30 PM EDT - 1 year ago

Novavax Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Aug 8, 2024, 8:30 AM EDT - 1 year ago

Novavax Earnings Call Transcript: Q2 2024

Jun 6, 2024, 12:30 PM EDT - 2 years ago

Novavax Transcript: Jefferies 2024 Global Healthcare Conference

May 15, 2024, 6:00 PM EDT - 2 years ago

Novavax Transcript: Bank of America Health Care Conference 2024

May 10, 2024, 8:30 AM EDT - 2 years ago

Novavax Earnings Call Transcript: Q1 2024

Mar 6, 2024, 1:30 PM EST - 2 years ago

Novavax Transcript: TD Cowen 44th Annual Health Care Conference 2024

Feb 28, 2024, 8:30 AM EST - 2 years ago

Novavax Earnings Call Transcript: Q4 2023

Jan 8, 2024, 8:15 PM EST - 2 years ago

Novavax Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Nov 15, 2023, 4:00 AM EST - 2 years ago

Novavax Transcript: 14th Annual Jefferies London Healthcare Conference 2023

Nov 9, 2023, 8:30 AM EST - 2 years ago

Novavax Earnings Call Transcript: Q3 2023

Sep 12, 2023, 10:15 AM EDT - 2 years ago

Novavax Transcript: Baird's Global Healthcare Conference 2023

Sep 11, 2023, 4:30 PM EDT - 2 years ago

Novavax Transcript: H.C. Wainwright 25th Annual Global Investment Conference

Aug 8, 2023, 8:30 AM EDT - 2 years ago

Novavax Earnings Call Transcript: Q2 2023

May 11, 2023, 1:00 PM EDT - 3 years ago

Novavax Transcript: Bank of America Global Healthcare Conference

May 9, 2023, 8:30 AM EDT - 3 years ago

Novavax Earnings Call Transcript: Q1 2023

Feb 28, 2023, 4:30 PM EST - 3 years ago

Novavax Earnings Call Transcript: Q4 2022

Jan 9, 2023, 8:15 PM EST - 3 years ago

Novavax Transcript: JPMorgan Healthcare Conference

Nov 8, 2022, 3:30 AM EST - 3 years ago

Novavax Earnings Call Transcript: Q3 2022

Aug 8, 2022, 6:27 AM EDT - 4 years ago

Novavax Earnings Call Transcript: Q2 2022

May 9, 2022, 5:28 AM EDT - 4 years ago

Novavax Earnings Call Transcript: Q1 2022

Feb 28, 2022, 4:38 AM EST - 4 years ago

Novavax Earnings Call Transcript: Q4 2021

Feb 10, 2022, 4:30 PM EST - 4 years ago

Novavax Transcript: Study Result

Dec 22, 2021, 4:30 PM EST - 4 years ago

Novavax Transcript: Study Result

Nov 3, 2021, 8:00 PM EDT - 4 years ago

Novavax Earnings Call Transcript: Q3 2021

Sep 21, 2021, 8:50 AM EDT - 4 years ago

Novavax Transcript: Status Update

Aug 5, 2021, 1:58 PM EDT - 5 years ago

Novavax Earnings Call Transcript: Q2 2021

Jun 14, 2021, 8:30 AM EDT - 5 years ago

Novavax Transcript: Study Result

May 10, 2021, 5:30 PM EDT - 5 years ago

Novavax Earnings Call Transcript: Q1 2021

Mar 1, 2021, 4:30 PM EST - 5 years ago

Novavax Earnings Call Transcript: Q4 2020

Jan 28, 2021, 4:30 PM EST - 5 years ago

Novavax Transcript: Status Update

Nov 10, 2020, 4:30 PM EST - 5 years ago

Novavax Earnings Call Transcript: Q3 2020

Nov 9, 2020, 4:30 PM EST - 5 years ago

Novavax Earnings Call Transcript: Q3 2020

Aug 10, 2020, 4:30 PM EDT - 6 years ago

Novavax Earnings Call Transcript: Q2 2020

Aug 4, 2020, 5:00 PM EDT - 6 years ago

Novavax Transcript: Study Update

May 11, 2020, 4:30 PM EDT - 6 years ago

Novavax Earnings Call Transcript: Q1 2020

andy4343 Apr. 25 at 2:48 PM

$NVAX Novavax has spent over 4 billion dollars on Research and Development in the last 10 years and is still only worth 1.2 billion. This too shall pass.

1 · Reply

Paulchowda Apr. 25 at 11:16 AM

$NVAX it’s just playing possum, I stretched my legs about 1130ish this fell in pool, dried off and fed grapes this morning. It’s always me.🤷‍♂️

3 · Reply

Trader00995 Apr. 25 at 8:54 AM

$NVAX

1 · Reply

Jordand91 Apr. 25 at 2:50 AM

$NVAX is JJ ever gonna fuck off? I have no idea why this guy is still the ceo

0 · Reply

Kikii2 Apr. 25 at 1:23 AM

1 · Reply

shibacuty Apr. 25 at 1:05 AM

$NVAX target price?

0 · Reply

ejaXstoXX Apr. 25 at 12:57 AM

$NVAX 46.3M shorted shares 14.9D to cover

1 · Reply

KidTrader999 Apr. 24 at 11:51 PM

$NVAX very odd trading with NVAX today, for a Friday. I’m feeling there is news next week. I’m pretty much all in… again. Let’s wait and see

0 · Reply

simplehumble Apr. 24 at 11:32 PM

$NVAX - May or June Heading to Moon !!! Have a nice weekend!!

0 · Reply

BigCheeze2014 Apr. 24 at 11:11 PM

$NVAX Shorts are in command. Shah is full of hot air…can’t do shit!

0 · Reply

Gagethis Apr. 24 at 10:27 PM

$NVAX Mayby he can be a mute full time now!

0 · Reply

Gagethis Apr. 24 at 10:23 PM

$NVAX Have a good weekend and I hope JJ has time to think about being unemployed

0 · Reply

e0fknu2k Apr. 24 at 8:14 PM

$NVAX Closed green for this Friday. Have a good weekend everyone!

1 · Reply

Lalalilala Apr. 24 at 7:58 PM

$NVAX Novavax should start working on a future vaccine for a virus discovered in Kenya but not yet transmitted to humans... we'll have to wait for a human being to have a sexual urge for the whole planet to stop again and for Novavax to go back up to $250. 🤣🤣🤣 By then, maybe we can hope for a $10 billion buyout? 🤔

1 · Reply

Gagethis Apr. 24 at 7:57 PM

$NVAX FU JJ!!!!!! I HATE YOU!!

0 · Reply

stockpicker Apr. 24 at 7:56 PM

$NVAX Short Interest updated data is due out today, anyone have it? I bet we see another drop in SI. previous report was 44.9M shares short (down 10M shares short from Dec). Gold line on graph is SI % of Float. Another estimated major drop expected per Ortex

1 · Reply

ddirk Apr. 24 at 7:37 PM

$NVAX it when RED hope you make money now, buy back

0 · Reply

ajbski Apr. 24 at 7:35 PM

$NVAX NIH sponsored trial completed, results pending: “A Phase 1/2 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating the Immunogenicity and Safety of an (Matrix-M) Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-Seronegative Persons”. Trial ID NCT05683834 https://clinicaltrials.gov/study/NCT05683834?intr=Matrix-M%20Adjuvant&lastUpdPost=2026-04-01_2026-04-24&viewType=Card&rank=2

1 · Reply

Stan_The_Man_Erck Apr. 24 at 7:34 PM

$NVAX Come on $6.66

0 · Reply

Imposter333 Apr. 24 at 7:31 PM

$NVAX Shah prepping for EC......

0 · Reply

WPBFL Apr. 24 at 7:23 PM

$NVAX Just waiting and waiting for the green light to buy more. It never turns green. I think stuck in yellow. What happens when it turns green and everybody and their shorts wants to accelerate at once. Until then waiting for what seems like forever.

1 · Reply

ddirk Apr. 24 at 7:22 PM

$NVAX time to load up thanks shorts

1 · Reply

Market Cap	1.33B
Revenue (ttm)	1.12B
Net Income (ttm)	440.30M
EPS (ttm)	N/A
PE Ratio	2.78
Forward PE	N/A
Profit Margin	39.19%
Debt to Equity Ratio	0.00

Volume	1,788,600
Avg Vol	4,246,828
Day's Range	N/A - N/A
Shares Out	162.94M
Stochastic %K	17%
Beta	2.65
Analysts	Sell
Price Target	$14.00